Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-07

Clinical Trial Update: Timolol Maleate Gel for the Treatment of Infantile Hemangioma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial of Timolol Maleate Gel for infantile hemangioma completed (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol Maleate Gel (timolol maleate)

Snippet

Sponsor: Auson Pharmaceuticals Inc. | Conditions: Infantile Hemangioma | Phase 2, Phase 3 | Status: COMPLETED